REYL & Cie S.A.’s Gilead Sciences GILD Stock Holding History

REYL & Cie S.A.’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$248K	Buy	+1,773	New	+$234K	0.29%	59

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

REYL & Cie S.A.'s GILD Position: Q2 2026 in Review

REYL & Cie S.A. opened a new position in Gilead Sciences (GILD) in Q2 2026: 1,773 shares worth $248K. The stake represents 0.29% of the portfolio and ranks #59 among its holdings.

2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

REYL & Cie S.A. held 1,773 shares of Gilead Sciences worth $248K as of Q2 2026.
Gilead Sciences was a new REYL & Cie S.A. position in Q2 2026.
Gilead Sciences made up 0.29% of REYL & Cie S.A.'s portfolio in Q2 2026, its #59 holding.
2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on REYL & Cie S.A.'s 13F filing for Q2 2026, filed 2 Oct 2026.